Trucheck is a blood test that can detect up to 70 solid tumours which account for 81% of all cancer cases and 84% of all cancer related deaths in Europe. The test has a 96% accuracy in determining the tissue or organ of origin in positive cases. Trucheck detects cancers irrespective of the extent of the disease, thus even early-stage cancers are reliably observed. Detection of early stage cancers is vital for successful treatments, lower toxicities and improved survival. Trucheck’s international research and innovation has been developed, tested and validated in over 40,000 individuals. The test consists of a blood draw transferral to the diagnostic laboratories with the result returned in approximately 2 weeks.
Trucheck is particularly recommended for:
- Asymptomatic individuals who have a family history of cancer.
- Individuals who want to include this test in their yearly check-up.
- Asymptomatic individuals who have a high risk in cancer.